Martin Midstream Partners (MMLP) Q3 2024 earnings summary

Executive summary

• Adjusted EBITDA for Q3 2024 was $25.1 million, slightly below guidance by $1.3 million due to higher long-term incentive plan expenses; year-to-date Adjusted EBITDA reached $87.3 million, tracking toward full-year guidance of $116.1 million.

• Entered into a definitive merger agreement on October 3, 2024, with Martin Resource Management Corporation (MRMC) to acquire all outstanding common units for $4.02 per unit in cash, pending regulatory and unitholder approval.

• Reported a net loss of $3.3 million for Q3 2024, compared to a net loss of $1.1 million in Q3 2023; net income for the nine months was $3.7 million.

• Declared a quarterly cash distribution of $0.005 per common unit for Q3 2024.

• Exited the butane optimization business, reducing commodity risk and volatility.

Financial highlights

• Q3 2024 revenues were $170.9 million, down from $176.7 million in Q3 2023; nine-month revenues were $536.3 million, down from $616.9 million year-over-year.

• Net income for 3Q 2024 was $8.6 million, with operating income at $12.7 million; interest expense for the quarter totaled $14.6 million.

• Distributable cash flow for Q3 2024 was $2.4 million, down from $5.0 million; adjusted free cash flow was negative $1.6 million for Q3 2024.

• Total debt outstanding increased to $486.6 million as of September 30, 2024, from $442.5 million at year-end 2023.

• Adjusted EBITDA margin for Q3 2024 was approximately 22% of total segment revenues.

Outlook and guidance

• Full-year 2024 Adjusted EBITDA guidance is $116.1 million, with Q4 2024 expected at $29.0 million.

• 2024 CapEx forecast is $57.4 million, with 2025 growth CapEx expected to decline as the ELSA project nears completion.

• 74% of 2024 EBITDA is expected to be service and fixed-fee based, providing stability amid market volatility.

• Management expects to remain in compliance with debt covenants for the next twelve months.

• The merger is expected to close following regulatory and unitholder approval; failure or delay could negatively impact financial results and unit price.